Merck KGaA, Darmstadt, Germany's Massachusetts-based Businesses Named 'Top Places to Work' by The Boston Globe

BILLERICA, Mass., Nov. 18, 2016 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based businesses have been named to The Boston Globe's annual "Top Places to Work" list.

This award marks the second of its kind in as many months. Last month, Merck KGaA, Darmstadt, Germany, ranked number 11 among the top 20 employers in the global biopharmaceutical industry by Science magazine, a leading peer-reviewed international scientific publication.  

"The recognition by The Boston Globe as a leading employer reflects our commitment to build a great science and technology company in the U.S., in one of the leading biotech and healthcare hubs in the world," said Udit Batra, CEO of the global life science business of Merck KGaA, Darmstadt, Germany and Member of the Executive Board. "We place great importance on fostering an environment that engenders both creative collaboration and problem solving. It's a win-win for both our employees and customers as we work together to advance science and medicine."

The Boston Globe's research partner, Workplace Dynamics, ranked 125 Massachusetts employers by analyzing employee responses to a confidential 24-question survey. The survey covered several topics including benefits, management and employee engagement.

"The fact that we achieved this recognition based on the positive input of our employees is extremely meaningful, as we are always exploring ways to ensure our company is one where everyone can do their best work each and every day," said Gary Zieziula, President and Managing Director, EMD Serono. "Our employees are going above and beyond to achieve our collective mission of accelerating innovation for difficult-to-treat diseases."

"We are very proud to be named as a Top Place to Work in Massachusetts, a key region for our business," said Warren Stone, Head of Research & Applied Commercial, MilliporeSigma. "We thank the employees surveyed for showing their engagement and commitment to the acceleration of science. It shows a sincere sense of connection and pride to both the community and our customers."

Top Places to Work recognizes the best places to work in the state based on internal employee surveys. Employers who enter to be surveyed are placed into one of four groups: small, with 50 to 99 employees; midsize, with 100 to 249 workers; large, with 250 to 999; and largest, with 1,000 or more. In total, the Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany employ approximately 2,300 people in Massachusetts.

All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

About EMD Serono, Inc.
EMD Serono is the biopharma business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology as R&D focus areas. Today, the business has 1,200 employees around the country with commercial, clinical and research operations based in the company's home state of Massachusetts.

About MilliporeSigma
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry. MilliporeSigma is a leading supplier in the life science industry. With products for protein research and cell biology as well as the manufacture of chemical‐based and biopharmaceutical drugs, MilliporeSigma covers the full bioprocessing value chain. Its aim is to solve the toughest problems in the industry by collaborating with the global scientific community.

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. The company holds the global rights to the "Merck" name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Logo - http://photos.prnewswire.com/prnh/20161117/440965LOGO

SOURCE Merck KGaA